In vitro toxicological effects of estrogenic mycotoxins on human placental cells: Structure activity relationships

Toxicology and Applied Pharmacology

Volumn 259, Issue 3, 2012, Pages 366-375

  Prouillac, Caroline ^a   Koraichi, Farah ^a   Videmann, Bernadette ^a   Mazallon, Michelle ^a   Rodriguez, Frédéric ^b   Baltas, Michel ^b   Lecoeur, Sylvaine ^a  

^a VETAGRO SUP   (France)

^b UPS)   (France)

Author keywords

ABC transporter; Differentiation; Mycotoxins; Nuclear receptor; Placenta; Zearalenone

Indexed keywords

ABC TRANSPORTER; ALPHA ZEARALENOL; BETA ZEARALENOL; BREAST CANCER RESISTANCE PROTEIN; CELL NUCLEUS RECEPTOR; CHORIONIC GONADOTROPIN; CYCLIC AMP; ESTROGEN RECEPTOR; LIVER X RECEPTOR; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROGESTERONE RECEPTOR; RETINOID X RECEPTOR; ZEARALENONE;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL VIABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; ESTROGEN ACTIVITY; ESTROGEN BINDING; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; METABOLITE; MOLECULAR DOCKING; PLACENTA; PROTEIN EXPRESSION; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION; SYNCYTIOTROPHOBLAST; TROPHOBLAST;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE; ESTROGENS, NON-STEROIDAL; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STRUCTURE-ACTIVITY RELATIONSHIP; TROPHOBLASTS; ZEARALENONE; ZERANOL;

ANIMALIA; FUSARIUM;

EID: 84858149901     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.01.016     Document Type: Article

References (39)

1. Abid-Essefi S., Ouanes Z., Hassen W., Baudrimont I., Creppy E., Bacha H. Cytotoxicity, inhibition of DNA and protein syntheses and oxidative damage in cultured cells exposed to zearalenone. Toxicol. in Vitro 2004, 18:467-474.
2. Al-Nasiry S., Spitz B., Hanssens M., Luyten C., Pijnenborg R. Differential effects of inducers of syncytialization and apoptosis on BeWo and JEG-3 choriocarcinoma cells. Hum. Reprod. 2006, 21:193-201.
3. Ayed-Boussema I., Pascussi J.M., Maurel P., Bacha H., Hassen W. Zearalenone activates pregnane X receptor, constitutive androstane receptor and aryl hydrocarbon receptor and corresponding phase I target genes mRNA in primary cultures of human hepatocytes. Environ. Toxicol. Pharmacol. 2011, 31:79-87.
4. Cartwright J.E., Fraser R., Leslie K., Wallace A.E., James J.L. Remodelling at the maternal-foetal interface: relevance to human pregnancy disorders. Reprod. Res. 2010, 140:803-813.
5. Chen Y.X., Allars M., Maiti K., Angeli G.L., Abou-Seif C., Smith R. Factors affecting cytotrophoblast cell viability and differentiation: evidence of a link between syncytialisation and apoptosis. Int. J. Biochem. Cell Biol. 2011, 43:821-828.
6. Chisaki I., Kobayashi M., Itagaki S., Hirano T., Iseki K. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP. Biochim. Biophys. Acta 2009, 1788(11):2396-2403.
7. Cole L.A. Biological functions of hCG and hCG-related molecules. Reprod. Biol. Endocrinol. 2010, 8:102-116.
8. Cronier L., Guibourdenche J., Nigera C., Malassiné A. Oestradiol stimulates morphological and functional differentiation of human villous cytotrophoblast. Placenta 1999, 20:669-676.
9. Delidaki M., Gu M., Hein A., Vatish M., Grammatopoulos D.K. Interplay of cAMP and MAPK pathways in hCG secretion and fusogenic gene expression in a trophoblastic cell line. Mol. Cell. Endocrinol. 2010, 332(1-2):213-220.
10. Ding X., Lichti K., Staudinger J.L. The mycoestrogen zearalenone induces CYP3A through activation of the pregnane X receptor. Toxicol. Sci. 2006, 91:448-455.
11. Gauster M., Moser G., Orendi K., Huppertz B. Factors involved in regulating trophoblast fusion: potential role in the development of preeclampsia. Placenta 2009, 30:S49-S54.
12. Guibourdenche J., Fournier T., Malassiné A., Evain-Brion D. Development and hormonal functions of the human placenta. Folia Histochem. Cytobiol. 2009, 47:S35-S42.
13. Handschuh K., Guibourdenche J., Cocquebert M., Tsatsaris V., Vidaud M., Evain-Brion D., Fournier T. Expression and regulation by PPARγ of hCG α- and β-subunits: comparison between villous and invasive extravillous trophoblastic cells. Placenta 2009, 30:1016-1022.
14. Handwerger S. New insights into the regulation of human cytotrophoblast cell differentiation. Mol. Cell. Endocrinol. 2010, 323:94-104.
15. IARC Overall evaluations of carcinogenicity to humans. International Agency for Research on Cancer. IARC Monographs 1999, vols. 1-73:1-36.
16. Kast R., Goodwin B., Tarr P.T., Jones S.A., Anisfeld A.M., Stoltz C.M., Tontonoz P., Kliewer S., Willson T.M., Edwards P.A. Regulation of multidrug resistance associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 2002, 277(4):2908-2915.
17. Keryer G., Alsat E., Taskén K., Evain-Brion D. Cyclic AMP-dependent protein kinases and human trophoblast cell differentiation in vitro. J. Cell Sci. 1998, 111:995-1004.
18. Malekinejad H., Maas-Bakker R., Fink-Gremmels J. Species differences in the hepatic biotransformation of zearalenone. Vet. J. 2006, 172:96-102.
19. Massart F., Meucci V., Saggese G., Soldani G. High growth rate of girls with precocious puberty exposed to estrogenic mycotoxins. J. Pediatr. 2008, 152:690-695.
20. Minervini F., Giannoccaro A., Cavallini A., Visconti A. Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters. Toxicol. Lett. 2005, 159:272-283.
21. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., Milburn M.V. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 1998, 395(6698):137-143.
22. Orendi K., Gauster M., Mose G., Meiri H., Huppertz B. The choriocarcinoma cell line BeWo: syncytial fusion and expression of syncytium-specific proteins. Reproduction 2010, 140:759-766.
23. Ouanes-Ben Othmen Z., El Golli E., Abid-Essefi S., Bacha H. Cytotoxicity effects induced by Zearalenone metabolites, α Zearalenol and βZearalenol, on cultured Vero cells. Toxicology 2008, 252:72-77.
24. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
25. Pötgens A.J.G., Drewlo S., Kokozidou M., Kaufmann P. Syncytin: the major regulator of trophoblast fusion? Recent developments and hypotheses on its action. Hum. Reprod. Update 2004, 10:487-496.
26. Prouillac C., Lecoeur S. The role of the placenta in foetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies. Drug Metab. Dispos. 2010, 38(10):1623-1635.
27. Prouillac C., Videmann B., Mazallon M., Lecoeur S. Induction of cells differentiation and ABC transporters expression by a myco-estrogen, zearalenone, in human choriocarcinoma cell line (BeWo). Toxicology 2009, 263:100-107.
28. Shi Q.J., Lei Z.M., Rao C.V., Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology 1993, 132:1387-1395.
29. Szuetz P., Mesterhazy A., Falkay G.Y., Bartyok T. Early telearche symptoms in children and their relations to zearalenone contamination in foodstuffs. Cereal Res. Commun. 1997, 25:429-436.
30. Tarrade T., Schoonjans K., Guibourdenche J., Bidart J.M., Vidaud M., Auwerx J., Rochette-Egly C., Evain-Brion D. PPAR{gamma}/RXR{alpha} heterodimers are involved in human CG{beta} synthesis and human trophoblast differentiation. Endocrinology 2001, 142:4504-4514.
31. Tomaszewski J., Miturski R., Semczuk A., Kotarski J., Jakowicki J. Tissue zearalenone concentration in normal, hyperplastic and neoplastic human endometrium. Ginekol. Pol. 1998, 69:363-366.
32. Vargas A., Moreau J., Landry S., LeBellego F., Toufaily C., Rassart E., Lafond J., Barbeau B. Syncytin-2 plays an important role in the fusion of human trophoblast cells. J. Mol. Biol. 2009, 392:301-318.
33. Wang H., Zhouv F., Gupta A., Vethanayagam R.R., Zhang Y., Unadkat J.D., Mao Q. Regulation of BCRP/ABCG2 expression by progesterone and 17β-estradiol in human placental BeWo cells. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E798-E807.
34. Wang H., Lee E.W., Zhou L., Leung P.C.K., Ross D.D., Unadkat J.D., Mao Q. Progesterone Receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo Cells. Mol. Pharmacol. 2008, 73:845-854.
35. Weedon-Fekjaer M.S., Duttaroy A.K., Nebb H.I. Liver X receptors mediate inhibition of hCG secretion in a human placental trophoblast cell line. Placenta 2005, 26:721-728.
36. Williams S.P., Sigler P.B. Atomic structure of progesterone complexed with its receptor. Nature 1998, 393:392-396.
37. Yang M., Lei Z.M., Rao C.V. The central role of human chorionic gonadotropin in the formation of human placental syncytium. Endocrinology 2003, 144:1108-1120.
38. Yoshie M., Kaneyama K., Kusama K., Higuma C., Nishi H., Isaka K., Tamura K. Possible role of the exchange protein directly activated by cyclic AMP (Epac) in the cyclic AMP-dependent functional differentiation and syncytialization of human placental BeWo cells. Hum. Reprod. 2010, 25:2229-2238.
39. Zinedine A., Soriano J.M., Molto J.C., Manes J. Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food Chem. Toxicol. 2007, 45:1-18.